Corindus Vascular Robotics to Present at the 37th Annual Cowen & Company Healthcare Conference

WALTHAM, Mass.--()--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, today announced that it will participate in the 37th Annual Cowen & Co. Healthcare Conference in Boston, MA.

Corindus Vascular’s management is scheduled to present on Wednesday, March 8, 2017 at 8:40 a.m. ET. Interested parties can access a live webcast on the investor relations section of the Company’s website at: www.corindus.com.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary interventions. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.

Contacts

Corindus Vascular Robotics, Inc.
Kate Stanton, 508-653-3335 ext. 200
kate.stanton@corindus.com
or
Lynn Pieper Lewis, 415-937-5402
ir@corindus.com

Release Summary

Corindus Vascular to present at Cowen Conference on Wednesday, March 8, 2017 at 8:40 a.m. ET

Contacts

Corindus Vascular Robotics, Inc.
Kate Stanton, 508-653-3335 ext. 200
kate.stanton@corindus.com
or
Lynn Pieper Lewis, 415-937-5402
ir@corindus.com